Treatment capacity required for full-scale implementation of lung cancer screening in the United States.

ABSTRACT:

Background

Full-scale implementation of lung cancer screening in the United States will increase detection of early stages. This study was aimed at assessing the capacity required for treating those cancers.

Methods

A well-established microsimulation model was extended with treatment data from the National Cancer Database. We assessed how treatment demand would change when implementing lung cancer screening in 2018. Three policies were assessed: 1) annual screening of current smokers and former smokers who quit fewer than 15 years ago, aged 55 to 80 years, with a smoking history of at least 30 pack-years (US Preventive Services Task Force [USPSTF] recommendations); 2) annual screening of current smokers and former smokers who quit fewer than 15 years ago, aged 55 to 77 years

SUBMITTER: Blom EF 

PROVIDER: S-EPMC6541509 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature